98-5669. Manufacturer of Controlled Substances; Notice of Application  

  • [Federal Register Volume 63, Number 43 (Thursday, March 5, 1998)]
    [Notices]
    [Pages 10945-10946]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-5669]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Drug Enforcement Administration
    
    
    Manufacturer of Controlled Substances; Notice of Application
    
        Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
    Regulations (CFR), this is notice that on December 18, 1997, Noramco of 
    Delaware, Inc., Division of McNeilab, Inc., 500 Old Swedes Landing 
    Road, Wilmington, Delaware 19801, made application by renewal to the 
    Drug Enforcement Administration (DEA) for registration as a bulk 
    manufacturer of the basic classes of controlled substances listed 
    below:
    
    ------------------------------------------------------------------------
                        Drug                               Schedule         
    ------------------------------------------------------------------------
    Codeine (9050).............................  II                         
    Oxycodone (9143)...........................  II                         
    Hydrocodone (9193).........................  II                         
    Morphine (9300)............................  II                         
    Thebaine (9333)............................  II                         
    ------------------------------------------------------------------------
    
        The firm plans to manufacture the listed controlled substances for 
    distribution to its customers as bulk product.
    
    [[Page 10946]]
    
        Any other such applicant and any person who is presently registered 
    with DEA to manufacture such substances may file comments or objections 
    to the issuance of the proposed registration.
        Any such comments or objections may be addressed, in quintuplicate, 
    to the Deputy Assistant Administrator, Office of Diversion Control, 
    Drug Enforcement Administration, United States Department of Justice, 
    Washington, D.C. 20537, Attention: DEA Federal Register Representative 
    (CCR), and must be filed no later than May 4, 1998.
    
        Dated: February 24, 1998.
    John H. King,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 98-5669 Filed 3-4-98; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
03/05/1998
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
98-5669
Pages:
10945-10946 (2 pages)
PDF File:
98-5669.pdf